Corynebacterium genitalium Furness and Evangelista
商品貨號
B219013
Strain Designations
418H
Isolation
Clinical isolate
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties
Type II
RefFurness G, et al. Corynebacterium pseudogenitalium sp. nov. Commensals of the human male and female urogenital tracts. Invest. Urol. 16: 292-295, 1979. PubMed: 429123
Product Format
freeze-dried
Preceptrol®
no
Type Strain
no
Medium
ATCC® Medium 1061: Trypticase soy with 0.1% Tween 80
Growth Conditions
Temperature: 37.0°C
Name of Depositor
G Furness
References
Furness G, et al. Corynebacterium pseudogenitalium sp. nov. Commensals of the human male and female urogenital tracts. Invest. Urol. 16: 292-295, 1979. PubMed: 429123
Furness G, et al. Corynebacterium pseudogenitalium sp. nov. Commensals of the human male and female urogenital tracts. Invest. Urol. 16: 292-295, 1979. PubMed: 429123
Furness G, et al. Corynebacterium pseudogenitalium sp. nov. Commensals of the human male and female urogenital tracts. Invest. Urol. 16: 292-295, 1979. PubMed: 429123
Cross References
Nucleotide (GenBank) :
AX110985
Sequence 1718 from Patent WO0123604.